Amit Hazan
Stock Analyst at Goldman Sachs
(2.10)
# 3,005
Out of 5,090 analysts
95
Total ratings
56.25%
Success rate
1.33%
Average return
Main Sectors:
Stocks Rated by Amit Hazan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Upgrades: Buy | n/a | $136.81 | - | 3 | Dec 13, 2022 | |
| BVS Bioventus | Maintains: Neutral | $13 → $2.5 | $7.09 | -64.74% | 5 | Nov 30, 2022 | |
| SKIN The Beauty Health Company | Maintains: Buy | $22 → $19 | $1.46 | +1,201.37% | 4 | Nov 23, 2022 | |
| SHC Sotera Health Company | Maintains: Neutral | $9 → $8 | $16.75 | -52.24% | 4 | Nov 23, 2022 | |
| LIVN LivaNova | Maintains: Buy | $73 → $63 | $63.36 | -0.57% | 3 | Nov 23, 2022 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $319 → $272 | $193.96 | +40.24% | 8 | Nov 23, 2022 | |
| BLCO Bausch + Lomb | Maintains: Neutral | $19 → $17 | $16.82 | +1.07% | 3 | Nov 23, 2022 | |
| OM Outset Medical | Maintains: Buy | $510 → $435 | $4.39 | +9,808.88% | 2 | Nov 9, 2022 | |
| PRCT PROCEPT BioRobotics | Maintains: Neutral | $39 → $44 | $35.86 | +22.70% | 2 | Nov 4, 2022 | |
| EW Edwards Lifesciences | Maintains: Neutral | $97 → $73 | $86.19 | -15.30% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $60 → $53 | $18.54 | +185.87% | 11 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $57 | $27.02 | +110.95% | 1 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $9.5 | $21.45 | -55.71% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $111 → $104 | $125.08 | -16.85% | 7 | Jul 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $60 | $17.77 | +237.65% | 3 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $129 → $115 | $101.36 | +13.46% | 9 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $248 → $150 | $364.02 | -58.79% | 2 | Apr 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $46 | $97.52 | -52.83% | 1 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $242 | $575.34 | -58.00% | 8 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $177 | $94.28 | +87.74% | 5 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $139 → $147 | $201.93 | -27.20% | 6 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $3.5 → $3.9 | $0.99 | +295.74% | 3 | Nov 1, 2018 |
Inspire Medical Systems
Dec 13, 2022
Upgrades: Buy
Price Target: n/a
Current: $136.81
Upside: -
Bioventus
Nov 30, 2022
Maintains: Neutral
Price Target: $13 → $2.5
Current: $7.09
Upside: -64.74%
The Beauty Health Company
Nov 23, 2022
Maintains: Buy
Price Target: $22 → $19
Current: $1.46
Upside: +1,201.37%
Sotera Health Company
Nov 23, 2022
Maintains: Neutral
Price Target: $9 → $8
Current: $16.75
Upside: -52.24%
LivaNova
Nov 23, 2022
Maintains: Buy
Price Target: $73 → $63
Current: $63.36
Upside: -0.57%
Becton, Dickinson and Company
Nov 23, 2022
Maintains: Buy
Price Target: $319 → $272
Current: $193.96
Upside: +40.24%
Bausch + Lomb
Nov 23, 2022
Maintains: Neutral
Price Target: $19 → $17
Current: $16.82
Upside: +1.07%
Outset Medical
Nov 9, 2022
Maintains: Buy
Price Target: $510 → $435
Current: $4.39
Upside: +9,808.88%
PROCEPT BioRobotics
Nov 4, 2022
Maintains: Neutral
Price Target: $39 → $44
Current: $35.86
Upside: +22.70%
Edwards Lifesciences
Nov 3, 2022
Maintains: Neutral
Price Target: $97 → $73
Current: $86.19
Upside: -15.30%
Nov 3, 2022
Maintains: Sell
Price Target: $60 → $53
Current: $18.54
Upside: +185.87%
Oct 11, 2022
Initiates: Buy
Price Target: $57
Current: $27.02
Upside: +110.95%
Aug 8, 2022
Maintains: Neutral
Price Target: $11 → $9.5
Current: $21.45
Upside: -55.71%
Jul 25, 2022
Maintains: Sell
Price Target: $111 → $104
Current: $125.08
Upside: -16.85%
Jul 14, 2022
Maintains: Neutral
Price Target: $80 → $60
Current: $17.77
Upside: +237.65%
Jan 18, 2022
Maintains: Neutral
Price Target: $129 → $115
Current: $101.36
Upside: +13.46%
Apr 1, 2020
Downgrades: Sell
Price Target: $248 → $150
Current: $364.02
Upside: -58.79%
Feb 13, 2020
Initiates: Neutral
Price Target: $46
Current: $97.52
Upside: -52.83%
Feb 13, 2020
Initiates: Buy
Price Target: $242
Current: $575.34
Upside: -58.00%
Feb 13, 2020
Initiates: Buy
Price Target: $177
Current: $94.28
Upside: +87.74%
Feb 25, 2019
Maintains: Neutral
Price Target: $139 → $147
Current: $201.93
Upside: -27.20%
Nov 1, 2018
Upgrades: Neutral
Price Target: $3.5 → $3.9
Current: $0.99
Upside: +295.74%